Quality of life assessment of relapsing-remitting multiple sclerosis patients on long-term treatment with Betaferon

被引：0
|
作者：
Davidescu, I.
Damian, G.
机构：
[1] Colentina Hosp, Dept Neurol, Bucharest, Romania
[2] UMF Carol Davila, Bucharest, Romania
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [31] Relation between acute exacerbations and long-term disability in patients with relapsing-remitting multiple sclerosis
    Gaillard, N
    Fabrot-Perray, R
    Lebayon, A
    Castelnovo, G
    Labauge, P
    MULTIPLE SCLEROSIS, 2005, 11 : S111 - S111
  • [32] Risk Factors for Poor Adherence to Betaferon® Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome
    Jernas, Lukasz
    Wencel, Jacek
    Wiak, Andrzej
    Bieniek, Marek
    Bartosik-Psujek, Halina
    PLOS ONE, 2016, 11 (10):
  • [33] Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Diouf, Ibrahima
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Onofrj, Marco
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, R. M. M.
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Cartechini, Elisabetta
    Van Pesch, Vincent
    Iuliano, Gerardo
    Granella, Franco
    Bergamaschi, Roberto
    Fernandez Bolanos, Ricardo
    Spitaleri, Daniele Litterio A.
    Slee, Mark
    Vucic, Ostoja
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Petersen, Thor
    Verheul, Freek
    Prevost, Julie
    Olascoaga Urtaza, Francisco Javier
    Cristiano, Edgardo
    Butzkueven, Helmut
    NEUROLOGY, 2020, 94 (15)
  • [34] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [35] Early prediction of the long-term response to interferon beta in relapsing-remitting multiple sclerosis patients
    Schmit, E.
    Gourraud, P. A.
    Couturier, N.
    Le Page, E.
    Vukusic, S.
    Debouverie, M.
    Defer, G. L.
    Lebrun, C.
    Frangoulis, B.
    Achiti, J.
    Merle, H.
    Edan, G.
    Fontaine, B.
    Clanet, M.
    Brassat, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S58 - S59
  • [36] Long-term B-Lymphocyte Depletion With Rituximab in Patients With Relapsing-Remitting Multiple Sclerosis
    Stuve, Olaf
    Leussink, Verena I.
    Froehlich, Ruth
    Hemmer, Bernhard
    Hartung, Hans-Peter
    Menge, Til
    Kieseier, Bernd C.
    ARCHIVES OF NEUROLOGY, 2009, 66 (02) : 259 - 261
  • [37] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 640 - 640
  • [38] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    SWISS MEDICAL WEEKLY, 2016, 146 : 80S - 80S
  • [39] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, Chiara
    Roth, Serge
    Findling, Oliver
    Perriard, Guillaume
    Bachmann, Valerie
    Pless, Misha L.
    Baumann, Andreas
    Kamm, Christian P.
    Lalive, Patrice H.
    Czaplinski, Adam
    NEUROLOGY, 2017, 88
  • [40] LONG-TERM INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - 3 YEARS EXPERIENCE
    ACHIRON, A
    ZIV, I
    GILAD, R
    DJALDETTI, R
    ZOLDAN, Y
    SAROVAPINHAS, I
    MELAMED, E
    ANNALS OF NEUROLOGY, 1993, 34 (02) : 275 - 275
12345